微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 0.72% | 2.29% | 101.61% | 75/139 | 1.16% | 惠泰医疗 | 7.54% | 行业排名> |
| 2025-12-31 | -44.51% | -5663.75% | -3550.39% | 127/139 | 2.07% | 惠泰医疗 | 27.72% | 行业排名> |
| 2025-09-30 | 1.29% | -21.34% | 31.63% | 90/139 | 0.51% | 惠泰医疗 | 22.41% | 行业排名> |
| 2025-06-30 | 0.98% | 218.07% | 40% | 86/139 | 1.91% | 惠泰医疗 | 15.03% | 行业排名> |
| 2025-03-31 | 0.7% | 333.33% | -12.5% | 82/139 | 1.04% | 迈瑞医疗 | 7.06% | 行业排名> |
| 2024-12-31 | 0.8% | -20% | -51.22% | 91/139 | 3.02% | 迈瑞医疗 | 31.95% | 行业排名> |
| 2024-09-30 | 1.64% | -74.77% | 297.59% | 90/139 | 4.75% | 迈瑞医疗 | 28.68% | 行业排名> |
| 2024-06-30 | -0.83% | -147.43% | -176.67% | 111/139 | 2.98% | 迈瑞医疗 | 20.2% | 行业排名> |
| 2024-03-31 | -0.3% | -124.19% | -130% | 108/139 | 1.65% | 迈瑞医疗 | 9.12% | 行业排名> |
| 2023-12-31 | 1% | -56.71% | -84.62% | 97/139 | 4.92% | 迈瑞医疗 | 33.21% | 行业排名> |
| 2023-09-30 | 6.5% | 52.94% | 271.43% | 50/139 | 5.8% | 迈瑞医疗 | 28.34% | 行业排名> |
| 2023-06-30 | 1.75% | -25.85% | 41.13% | 87/139 | 3.8% | 迈瑞医疗 | 18.36% | 行业排名> |
| 2023-03-31 | 1.24% | 18.1% | -46.32% | 78/139 | 2.28% | 安杰思 | 8.56% | 行业排名> |
| 2022-12-31 | 2.31% | 10% | -45.65% | 106/139 | 12.93% | 九安医疗 | 146.56% | 行业排名> |
| 2022-09-30 | 4.25% | 19.05% | 80.08% | 88/139 | 12.7% | 九安医疗 | 140.94% | 行业排名> |
| 2022-06-30 | 2.36% | 34.09% | 124.76% | 91/139 | 9.24% | 九安医疗 | 142.25% | 行业排名> |
| 2022-03-31 | 1.05% | -16.67% | -50% | 85/139 | 6.21% | 九安医疗 | 142.71% | 行业排名> |
| 2021-12-31 | 2.1% | 250% | -41.18% | 114/139 | 17.28% | 热景生物 | 121.78% | 行业排名> |
| 2021-09-30 | 3.57% | 457.81% | 102.84% | 96/139 | 15.82% | 热景生物 | 99.69% | 行业排名> |
| 2021-06-30 | 1.76% | 1860% | 39.68% | 107/139 | 11.46% | 热景生物 | 99.09% | 行业排名> |
| 2021-03-31 | 1.26% | 121.05% | 190% | 87/139 | 6.18% | 热景生物 | 57.63% | 行业排名> |
| 2020-12-31 | -1.4% | 32.69% | -318.75% | 117/139 | 25.47% | 中红医疗 | 168% | 行业排名> |
| 2020-09-30 | 0.64% | -70.78% | 740% | 83/139 | 19.63% | 圣湘生物 | 112.46% | 行业排名> |
| 2020-06-30 | -0.1% | -107.63% | -117.54% | 103/139 | 15.03% | 博拓生物 | 108.13% | 行业排名> |
| 2020-03-31 | 0.57% | -5% | 127.4% | 65/139 | 3.37% | 圣湘生物 | 29.33% | 行业排名> |
| 2019-12-31 | -2.08% | -360% | -194.98% | 112/139 | 14.24% | 健尔康 | 84.09% | 行业排名> |
| 2019-09-30 | 2.19% | -48.71% | 67.18% | 58/139 | 10.37% | 祥生医疗 | 28.56% | 行业排名> |
| 2019-06-30 | 1.31% | -48.22% | 118.33% | 65/139 | 6.65% | 心脉医疗 | 31.04% | 行业排名> |
| 2019-03-31 | 0.6% | -68.59% | -25% | 47/139 | 2.68% | 新华医疗 | 13.55% | 行业排名> |
| 2018-12-31 | 0.8% | -89.61% | -81.26% | 97/139 | 12.87% | 安旭生物 | 48.71% | 行业排名> |
| 2018-09-30 | 4.27% | -48.18% | 68.77% | 45/139 | 7.11% | 迈瑞医疗 | 38.33% | 行业排名> |
| 2018-06-30 | 2.53% | -44.76% | 32.46% | 43/139 | 3.2% | *ST明德 | 14.54% | 行业排名> |
| 2018-03-31 | 1.91% | -23.9% | -75.19% | 33/139 | 2.61% | 迈瑞医疗 | 11% | 行业排名> |
| 2017-12-31 | 7.7% | -11.7% | -6.55% | 72/139 | 13.76% | 安旭生物 | 59.22% | 行业排名> |
| 2017-09-30 | 8.24% | 7.99% | 79.91% | 25/139 | 9.4% | 大博医疗 | 30.55% | 行业排名> |
| 2017-06-30 | 4.58% | -12.6% | 82.47% | 35/139 | 5.88% | 基蛋生物 | 23.11% | 行业排名> |
| 2017-03-31 | 2.51% | -16.33% | -71.22% | 19/139 | 2.65% | 基蛋生物 | 11.34% | 行业排名> |
| 2016-12-31 | 8.72% | -32.92% | 14.29% | 55/139 | 16.11% | 奥泰生物 | 76.87% | 行业排名> |
| 2016-09-30 | 7.63% | -49.07% | 45.61% | 18/139 | 8.66% | 安图生物 | 28% | 行业排名> |
| 2016-06-30 | 5.24% | -49.52% | 74.67% | 27/139 | 6.24% | *ST明德 | 23.29% | 行业排名> |
| 2016-03-31 | 3% | -41.86% | -76.92% | 11/139 | 2.17% | 健帆生物 | 7.75% | 行业排名> |